Discovery Pipeline

Oct 28, 2014
The Yale School of Medicine and Gilead will continue their research on cancer targets for a minimum of three additional years.
Oct 23, 2014
Secukinumab is the first IL-17A inhibitor to meet its primary endpoint in two Phase III trials for patients with ankylosing spondylitis.
Sep 26, 2014
By BioPharm International Editors
Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.
Sep 25, 2014
By BioPharm International Editors
USP expresses its support for a consensus-based global approach to the naming of biologics.
Jun 01, 2014
BioPharm International
By BioPharm International Editors
NIH study reveals a new cancer immunotherapy method could be effective against a range of cancers.
Jun 01, 2014
BioPharm International
By BioPharm International Editors
Johns Hopkins researchers use stem cells derived from human body fat to deliver treatment for brain tumors.
Jun 01, 2014
BioPharm International
By BioPharm International Editors
Researchers from Harvard have reproduced the structure, functions, and cellular make-up of bone marrow, to create a device known as bone marrow-on- a-chip.
May 08, 2014
By BioPharm International Editors
The Pediatric Clinical Research Group initiative expands to include pediatric research sites.
Apr 22, 2014
By BioPharm International Editors
Genetic evidence supports role of APOBEC gene family in cancer development.
Apr 22, 2014
By BioPharm International Editors
University of Michigan study demonstrates how a Silly Putty ingredient could advance stem cell therapies.
native1_300x100
lorem ipsum